VBI Vaccines Inc. (LO9A.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 08:20AM CEST
| Previous Close | 0.5510 |
| Open | 0.5540 |
| Bid | 0.5660 x N/A |
| Ask | 0.5810 x N/A |
| Day's Range | 0.5540 - 0.5540 |
| 52 Week Range | 0.4200 - 2.9700 |
| Volume | |
| Avg. Volume | 174 |
| Market Cap | 16.619M |
| Beta (5Y Monthly) | 1.92 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates
Puma Biotech (PBYI) delivered earnings and revenue surprises of 42.86% and 6.29%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
VBI Vaccines Inc.'s (NASDAQ:VBIV) Intrinsic Value Is Potentially 30% Above Its Share Price
Key Insights The projected fair value for VBI Vaccines is US$3.70 based on 2 Stage Free Cash Flow to Equity Current...
- Zacks
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Misses Revenue Estimates
VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of -7.05% and 40.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.